Explosive demand for GPL-1 agonists and the broadening applications of therapeutics oligonucleotides are fueling urgent innovation in manufacturing approaches that balance both scale and sustainability. Cambridge Healthtech Institute’s Inaugural Peptide and Oligo Manufacturing conference convenes experts from the worlds of bioprocessing and process chemistry to explore the latest developments in synthetic, hybrid, and recombinant production platforms to improve the production of therapeutic peptides, antimicrobials, ASOs, siRNAs, and more. Sessions will address advances in solid and liquid-phase synthesis, upstream and downstream processing, expression systems, continuous purification, green chemistry, drug product and formulation, and overcoming challenges with conjugated and non-canonical molecules. Examples come from therapeutic peptides, antimicrobials, ASOs, siRNAs, and more.

Conferences Include: